-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MUuyQ72FbhWtlZ2VvTFtvROPt4+QOCAv7tcFOViE/JiPVMFu04pnlDZ96lUuPBmA FBWslGMyYoIyaQqQXy7xHQ== 0001144204-06-013846.txt : 20060404 0001144204-06-013846.hdr.sgml : 20060404 20060404170247 ACCESSION NUMBER: 0001144204-06-013846 CONFORMED SUBMISSION TYPE: POS AM PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20060404 DATE AS OF CHANGE: 20060404 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GLYCOGENESYS INC CENTRAL INDEX KEY: 0000946661 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330231238 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: POS AM SEC ACT: 1933 Act SEC FILE NUMBER: 333-38964 FILM NUMBER: 06739025 BUSINESS ADDRESS: STREET 1: 31 ST. JAMES AVENUE STREET 2: 8TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 6174220674 MAIL ADDRESS: STREET 1: 31 ST JAMES AVE STREET 2: 8TH FL CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: GLYCOGENESY INC DATE OF NAME CHANGE: 20011107 FORMER COMPANY: FORMER CONFORMED NAME: SAFESCIENCE INC DATE OF NAME CHANGE: 19980401 FORMER COMPANY: FORMER CONFORMED NAME: IGG INTERNATIONAL INC DATE OF NAME CHANGE: 19950721 POS AM 1 v039587_posam.htm
 
As filed with the Securities and Exchange Commission on April 4, 2006
Registration No. 333-38964
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________________
 
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8
REGISTRATION STATEMENT UNDER
THE SECURITIES ACT OF 1933
____________________________
 
GLYCOGENESYS, INC.
(Exact name of registrant as specified in its charter)
 
  Nevada   33-0231238
 
(State or other jurisdiction of
incorporation or organization)
  
(I.R.S. Employer
Identification No.)
 
31 St. James Avenue
Boston, Massachusetts 02116
(Address of principal executive offices, including zip code)
_____________________________
 
2000 STOCK INCENTIVE PLAN, AS AMENDED
(Full title of the Plan)
 
Frederick E. Pierce, II
Interim Chief Executive Officer
GlycoGenesys, Inc.
31 St. James Avenue
Boston, Massachusetts 02116
(Name and address of agent for service)
 
(617) 422-0674
(Telephone number, including area code, of agent for service)
 

DEREGISTRATION OF SHARES
 
GlycoGenesys, Inc. (the “Company”) originally filed a Registration Statement on Form S-8 (File No. 333-38964) (the “Registration Statement”) which registered 166,667 shares (on a post reverse split basis) of common stock reserved for issuance under the Company’s 2000 Stock Incentive Plan, as amended (the “Plan”). This Post-Effective Amendment No. 1 to the Registration Statement is being filed to deregister all shares of common stock reserved for issuance under the Plan that have not yet been issued. As a result of this deregistration, no shares of common stock remain registered for sale pursuant to the Registration Statement.




SIGNATURES
 
Pursuant to the requirements of the Securities Act, the Company certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8, and has duly caused this Post-Effective Amendment No. 1 to the Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Boston, Commonwealth of Massachusetts on April 4, 2006.
 
     
  GlycoGenesys, Inc.
 
 		  
 		  
 
  By:   /s/ Frederick E. Pierce, II
 
Frederick E. Pierce, II
 
Interim Chief Executive Officer and
Vice President, Business Development
  
Pursuant to the requirements of the Securities Act, this Post-Effective Amendment No. 1 to the Registration Statement has been signed by the following persons in the capacities indicated on April 4, 2006.
 
Name and Signature
  
Title
 
    
/s/ Frederick E. Pierce, II
Frederick E. Pierce, II
  
Interim Chief Executive Officer,
Vice President, Business Development
(Principal Executive Officer)
 
    
*
Bradley J. Carver
  
Director
 
    
*
David W. Dube
  
Director
 
    
*
Michael E. Hanson
  
Director
 
    
*
Theodore J. Host
  
Director
 
    
/s/ John W. Burns
John W. Burns
  
Chief Financial Officer, Senior
Vice President, Secretary, Interim Chairman
and Director (Principal Financial Officer)
 
    
/s/ Patrick J. Joyce
Patrick J. Joyce
  
Controller
(Principal Accounting Officer)
 
     
   
 
 		  
 		  
 
  *By:   /s/ John W. Burns
 
Attorney-in-Fact
 
 -----END PRIVACY-ENHANCED MESSAGE-----